Work

Immune checkpoint inhibitors and timing of administration – Authors' reply

Year: 2022

Type: letter

Source: The Lancet Oncology

DOI: 10.1016/s1470-2045(22)00023-7

Authors: David C Qian, Zachary S Buchwald

Institutions: Winship Cancer Institute, Emory University

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Melanoma Research Alliance, National Institutes of Health

OpenAlex ID: W4210352521

Cites: 4

Cited by: 5

Related to: 10